Dopamine modification of glycolytic enzymes impairs glycolysis: possible implications for Parkinson’s disease

Abstract Background Parkinson’s disease (PD), a chronic and severe neurodegenerative disease, is pathologically characterized by the selective loss of nigrostriatal dopaminergic neurons. Dopamine (DA), the neurotransmitter produced by dopaminergic neurons, and its metabolites can covalently modify p...

Popoln opis

Bibliografske podrobnosti

Principais autores:	Bing Chen, Qian Zhang, Xiaoru Zhong, Xinwei Zhang, Xin Liu, Hongyang Wang, Fan Yang, Jingjing Zhang, Jingnan Huang, Yin-Kwan Wong, Piao Luo, Jigang Wang, Jichao Sun
Format:	Artigo
Jezik:	Inglês
Izdano:	BMC 2024-01-01
Serija:	Cell Communication and Signaling
Teme:	Dopamine (DA) Parkinson’s disease (PD) Glycolysis Mitochondrial dysfunction
Online dostop:	https://doi.org/10.1186/s12964-024-01478-0
Oznake:	Označite Brez oznak, prvi označite!